MUCORMYCOSIS IN HEMATOLOGIC PATIENTS: A REVIEW
Most invasive fungal infections occur in patients with hematologic malignancies and the prevalence has increased steadily in recent years due to intensive cytotoxic chemotherapies, stem cell transplantation, myeloablative radiation therapy, and the use of corticosteroids, cyclosporine or new immunos...
Saved in:
Main Authors: | García-Romero Maria Teresa (Author), García-Méndez Jorge (Author), Arenas Roberto (Author) |
---|---|
Format: | Book |
Published: |
Our Dermatology Online,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fatal Disseminated Mucormycosis in a Hematological Immunocompromised Patient with Extensive Voriconazole Exposure: A Case Report and Review of the Literature
by: Victoria S. Humphrey, et al.
Published: (2020) -
Clinical characteristics and mortality of mucormycosis in hematological malignancies: a retrospective study in Eastern China
by: Tao Suo, et al.
Published: (2024) -
Cutaneous mucormycosis
by: Ana Daniela Castrejón-Pérez, et al.
Published: (2017) -
Gastric mucormycosis
by: Sourav Bhowmik, et al.
Published: (2023) -
Angioinvasive mucormycosis in a patient with aplastic anemia
by: Aref Moshayedi, BS, et al.
Published: (2023)